HIV Replication Increases the Mitochondrial DNA Content of Plasma Extracellular Vesicles

HIV Replication Increases the Mitochondrial DNA Content of Plasma Extracellular Vesicles

Extracellular vesicles (EVs) and their cargo have been studied intensively as potential sources of biomarkers in HIV infection; however, their DNA content, particularly the mitochondrial portion (mtDNA), remains largely unexplored. It is well known that human immunodeficiency virus (HIV) infection a...

Full description

Bibliographic Details
Main Authors:	Wilfried Wenceslas Bazié, Julien Boucher, Benjamin Goyer, Dramane Kania, Isidore Tiandiogo Traoré, Diane Yirgnur Somé, Michel Alary, Caroline Gilbert
Format:	Article
Language:	English
Published:	MDPI AG 2023-01-01
Series:	International Journal of Molecular Sciences
Subjects:	extracellular vesicles HIV-1 mitochondrial DNA antiretroviral therapy tenofovir zidovudine
Online Access:	https://www.mdpi.com/1422-0067/24/3/1924

Similar Items

Plasma vesicular miR-155 as a biomarker of immune activation in antiretroviral treated people living with HIV
by: Wilfried Wenceslas Bazié, et al.
Published: (2022-08-01)

Vesicular MicroRNA as Potential Biomarkers of Viral Rebound
by: Wilfried Wenceslas Bazié, et al.
Published: (2022-03-01)

Comparison of the Effects of Three Dual-Nucleos(t)ide Reverse Transcriptase Inhibitor Backbones on Placenta Mitochondria Toxicity and Oxidative Stress Using a Mouse Pregnancy Model
by: Kayode Balogun, et al.
Published: (2022-05-01)

Factors associated to modification of first-line antiretroviral therapy due to adverse events in people living with HIV/AIDS
by: Larissa Negromonte Azevedo, et al.
Published: (2020-01-01)

Anemia in HIV/AIDS Patients on Antiretroviral Treatment at Ayder Specialized Hospital, Mekele, Ethiopia: A Case-Control Study
by: Berhane Y, et al.
Published: (2020-10-01)

Management of HIV-positive pregnant women: a Singapore experience
by: Loh, Michelle, et al.
Published: (2022)

Diurnal Variation of Plasma Extracellular Vesicle Is Disrupted in People Living with HIV
by: Wilfried Wenceslas Bazié, et al.
Published: (2021-04-01)

Estimating the length of the first antiretroviral therapy regiment durability in São Paulo, Brazil
by: Roseane Medeiros, et al.

Plasma Extracellular Vesicle Subtypes May be Useful as Potential Biomarkers of Immune Activation in People With HIV
by: Wilfried Wenceslas Bazié, et al.
Published: (2021-01-01)

Renal safety of tenofovir containing antiretroviral regimen in a Singapore cohort
by: Chua Arlene C, et al.
Published: (2012-06-01)

Effect of antiretroviral drug (arved) on hepatic enzymes in albino rats
by: D E Peters, et al.
Published: (2014-07-01)

Effect of Antiretroviral Drug (arved) on the Kidney in Albino Rat
by: D E Peters, et al.
Published: (2014-07-01)

A Comparison between the Efficiency of Vonavir (Tenofovir-Emtricitabine- Efavirenz) and Cobavir (Lamivudine-Zidovudine) with Efavirenz used for HIV Patients in Fasa, Iran
by: Saeideh Honarmand, et al.
Published: (2022-07-01)

Combination of Antiretroviral Drugs Zidovudine and Efavirenz Impairs Tumor Growths in a Mouse Model of Cancer
by: Marcel A. Schneider, et al.
Published: (2021-11-01)

Prolonged tenofovir treatment of macaques infected with K65R reverse transcriptase mutants of SIV results in the development of antiviral immune responses that control virus replication after drug withdrawal
by: Van Rompay Koen K A, et al.
Published: (2012-07-01)

Rates and predictors of switching to tenofovir alafenamide-containing ART in a nationwide cohort
by: Bernard Surial, et al.
Published: (2019-10-01)

Changing trends in lipid profile and biomarkers of renal function and bone metabolism before and after switching from tenofovir disoproxil fumarate to tenofovir alafenamide: a prospective observational study
by: Mahoko Ikeda, et al.
Published: (2021-05-01)

Immune Cells Release MicroRNA-155 Enriched Extracellular Vesicles That Promote HIV-1 Infection
by: Julien Boucher, et al.
Published: (2023-01-01)

Extracellular Vesicles in Viral Replication and Pathogenesis and Their Potential Role in Therapeutic Intervention
by: Asit Kumar, et al.
Published: (2020-08-01)

Incidence and association of renal dysfunction with a long term Tenofovir-based therapy among HIV-positive naïve cohort at Ronald Ross Hospital
by: Enock Wantakisha, et al.
Published: (2020-06-01)

Hair Zidovudine Concentrations Predict Virologic Outcomes Among People Living with HIV/AIDS in China
by: Wu Y, et al.
Published: (2022-08-01)

Administration of Fozivudine Tidoxil as a Single-Agent Therapeutic during Acute Feline Immunodeficiency Virus Infection Does Not Alter Chronic Infection
by: Jonathan E. Fogle, et al.
Published: (2012-06-01)

Post Exposure Prophylaxis for Occupational Exposures to HIV and Hepatitis B: Our Experience of Thirteen Years at a Rural Based Tertiary Care Teaching Hospital of Western India
by: Sanket Pranjivan Sheth, et al.
Published: (2016-08-01)

Evaluation of the Side Effects of Antiretroviral Treatment
by: Sedef BAŞGÖNÜL, et al.
Published: (2018-12-01)

Development and validation of analytical method for quantitation of Emtricitabine, Tenofovir, Efavirenz based on HPLC
by: Arun Ramaswamy, et al.
Published: (2018-02-01)

Tenofovir-induced quadriparesis
by: Ashalatha Muppur, et al.
Published: (2020-01-01)

Renal function in Ethiopian HIV-positive adults on antiretroviral treatment with and without tenofovir
by: Daniel Yilma, et al.
Published: (2020-08-01)

The evidence for using tenofovir disoproxil fumarate plus lamivudine as a nucleoside analogue backbone for the treatment of HIV
by: Laura Waters, et al.
Published: (2021-03-01)

Impact of antiretroviral therapy on cutaneous adverse drug reactions in adult HIV patients: A study from a tertiary care hospital
by: Tulasi Jarang, et al.
Published: (2024-04-01)

Validação de método por cromatografia líquida de alta eficiência para determinação da lamivudina e zidovudina em comprimidos Validation of a high performace liquid chromatography method for the determina of lamivudine and zidovudine in tablets
by: Ruy Carlos Ruver Beck, et al.
Published: (2007-10-01)

Liver Fibrosis during Antiretroviral Treatment in HIV-Infected Individuals. Truth or Tale?
by: Athanasios-Dimitrios Bakasis, et al.
Published: (2021-05-01)

Lipid profile after switching from TDF (tenofovir disoproxil)-containing to TAF (tenofovir alafenamide)-containing regimen in virologically suppressed people living with HIV
by: Michał Łomiak, et al.
Published: (2023-09-01)

A longitudinal study of renal function outcomes in a cohort of HIV patients on tenofovir-based antiretroviral therapy in Ashanti region, Ghana
by: E. Ahenkan, et al.
Published: (2023-07-01)

Real-world impact of switching from tenofovir disoproxil fumarate to tenofovir alafenamide
by: Sarah M Michienzi, et al.
Published: (2021-07-01)

Tenofovir-Containing Antiretroviral Therapy and Clinical Outcomes of SARS-CoV-2 Infection in People Living with HIV
by: María F. Rombini, et al.
Published: (2023-05-01)

A randomized clinical pharmacokinetic trial of Tenofovir in blood, plasma and urine in adults with perfect, moderate and low PrEP adherence: the TARGET study
by: Tim R. Cressey, et al.
Published: (2017-07-01)

Treatment with Commonly Used Antiretroviral Drugs Induces a Type I/III Interferon Signature in the Gut in the Absence of HIV Infection
by: Sean M. Hughes, et al.
Published: (2020-09-01)

Análise morfológica e fisiológica dos fígados e rins de ratas prenhes e seus fetos tratados pela associação zidovudina, lamivudina e ritonavir durante toda a prenhez Morphological and physiological analysis of livers and kidneys of pregnant rats and their fetuses treated by the association of zidovudine, lamivudine and ritonavir for the whole period of pregnancy
by: Adriana Wagner, et al.
Published: (2010-11-01)

Velocity Gradient Separation Reveals a New Extracellular Vesicle Population Enriched in miR-155 and Mitochondrial DNA
by: Myriam Vaillancourt, et al.
Published: (2021-04-01)

Duration of Zidovudine Consumption Correlates with Anemia in People Living with HIV
by: Danis Pertiwi, et al.
Published: (2023-05-01)